Atlas Trials

Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment

Clinical trial NCT06413082 · COMPLETED

Trial details

NCT number
NCT06413082
Sponsor
Ospedale San Raffaele
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypertensionGenetic PredispositionDrug Effect
Start date
2021-02-15
Primary completion
2023-07-07
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.